---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-042762"
form_type: "8-K"
ticker: "ATPC"
cik: "0001713210"
company_name: "Agape ATP Corp"
filed_at: "2023-11-27T23:59:59+00:00"
generated_at: "2026-06-07T21:31:16.719773+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Agape ATP elects Dr. Wilfrendo Fernando Cortizo as director effective Nov 21, 2023

## Summary
- Dr. Cortizo elected to the Board on November 21, 2023; no committee assignments yet.
- He brings over 30 years of experience in microbiology and biotechnology.
- No family relationships exist between Dr. Cortizo and any officer or director.
- No material transactions between Dr. Cortizo and the company in the past two years.

## SEC filing metadata
- accession: 0001493152-23-042762
- form_type: 8-K
- ticker: ATPC
- cik: 0001713210
- company_name: Agape ATP Corp
- filed_at: 2023-11-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1713210/000149315223042762/0001493152-23-042762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1713210/000149315223042762/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-042762
- JSON: https://secwatch.observer/filing/0001493152-23-042762.json
- Plain text: https://secwatch.observer/filing/0001493152-23-042762.txt

## Key facts
- Executive change
  Dr. Wilfrendo Fernando Cortizo was elected as director at Agape ATP Corp.
  - Action: elected
  - Role: director
  source text: elected Dr. Wilfrendo Fernando Cortizo, Phd (Dr. Cortizo) as a director of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1713210/000149315223042762/0001493152-23-042762-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.